Greenlight Biosciences Hldgs Pbc (GRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 25 |
| TOTAL | $25 |
| Non-Current Assets | |
| Other Non-Current Assets | 147 |
| TOTAL | $147 |
| Total Assets | $172 |
| Liabilities | |
| Current Liabilities | |
| Accrued Expenses | 39 |
| TOTAL | $148 |
| Non-Current Liabilities | |
| TOTAL | $N/A |
| Total Liabilities | $147 |
| Shareholders' Equity | |
| Shares Outstanding, K | 5,175 |
| Common Shares | 1 |
| Retained earnings | -1 |
| TOTAL | $24 |
| Total Liabilities And Equity | $171 |